title: Effect of peptide nicking in the human chorionic gonadotropin beta-subunit on stimulation of recombinant human thyroid-stimulating hormone receptors.
abstract: It is now generally accepted that human chorionic gonadotropin (hCG) has thyroid-stimulating activity. Heterologous forms of the hCG molecule occur in the purified preparations extracted from urine of pregnant women and patients with trophoblastic diseases. This work was undertaken to determine the effect of peptide nicking in the hCG-beta subunit on its thyrotropic potency. Using Chinese hamster ovary cells expressing functional human thyroid-stimulating hormone (TSH) receptors, we examined the effect of nicked hCG on cycliC AMP (cAMP) production and receptor binding. The effect of human leukocyte elastase (hLE), a nicking enzyme, on standard hCG also was examined in the cAMP assay and on receptor binding. We studied five hCG preparations extracted from the urine of normal pregnancy (CR-127 and P8) and trophoblastic diseases (C2, C5 and M4). Two preparations (C2, 96% nicked and M4, 100% nicked in the beta 44-49 region) showed about a 1.5-fold potency of standard hCG CR-127, which is also 20% nicked in the same region. Non-nicked hCG (P8) had the weakest potency among all of the samples tested. Treatment of standard hCG with hLE increased the cAMP response about two-fold. Dose-dependent displacement of bovine [125I]TSH by standard hCG and hLE increased the cAMP response about two-fold. Dose-dependent displacement of bovine [125I]TSH by standard hCG and hLE-digested hCG was observed and was almost identical. We have confirmed the increased in vitro thyrotropic activity of hCG nicked in the beta-intercysteine loop on recombinant human TSH receptors.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Endocrinology Research Laboratory, West Los Angeles Veterans Affairs Medical Center, CA.
authors.forename: M
authors.initials: M
authors.lastname: Yoshimura
authors.forename: A E
authors.initials: AE
authors.lastname: Pekary
authors.forename: X P
authors.initials: XP
authors.lastname: Pang
authors.forename: L
authors.initials: L
authors.lastname: Berg
authors.forename: L A
authors.initials: LA
authors.lastname: Cole
authors.forename: A
authors.initials: A
authors.lastname: Kardana
authors.forename: J M
authors.initials: JM
authors.lastname: Hershman
mesh_terms: D000818:Animals; D016466:CHO Cells; D006063:Chorionic Gonadotropin / Q000737:chemistry* / Q000378:metabolism / Q000502:physiology; D018997:Chorionic Gonadotropin, beta Subunit, Human; D006224:Cricetinae; D000242:Cyclic AMP / Q000096:biosynthesis; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D010446:Peptide Fragments / Q000737:chemistry* / Q000378:metabolism / Q000502:physiology; D011247:Pregnancy; D011989:Receptors, Thyrotropin / Q000378:metabolism / Q000502:physiology*; D011994:Recombinant Proteins / Q000378:metabolism
chemical_list: D006063:Chorionic Gonadotropin; D018997:Chorionic Gonadotropin, beta Subunit, Human; D010446:Peptide Fragments; D011989:Receptors, Thyrotropin; D011994:Recombinant Proteins; D000242:Cyclic AMP